Gulf Resources, Inc. 8-K Filing

FAQ

Key Financial Figures

• $0.0005 — nge on which registered Common Stock, $0.0005 par value GURE The Nasdaq Stock Mar

Filing Documents

• e665030_8k-gulfresources.htm (8-K) — 24KB
• e665030_ex10-1.htm (EX-10.1) — 30KB
• 0001193805-25-001737.txt ( ) — 223KB
• gure-20251215.xsd (EX-101.SCH) — 3KB
• gure-20251215_lab.xml (EX-101.LAB) — 33KB
• gure-20251215_pre.xml (EX-101.PRE) — 22KB
• e665030_8k-gulfresources_htm.xml (XML) — 4KB

01 Other Events

Item 8.01 Other Events. On December 10, 2025, Shouguang City Haoyuan Chemical Company Limited (the "Seller"), a company incorporated in the PRC and an indirect wholly owned subsidiary of Gulf Resources, Inc. (the "Company"), entered into an equity transfer agreement (the "SPA") with Shandong Rongyuan Pharmaceutical Co., Ltd. (the "Purchaser") and Shouguang Yuxin Chemical Industry Co., Limited (the "Target Company"). Pursuant to the SPA, the Seller agreed to sell, and the Purchaser agreed to purchase, 100% of the equity interests in the Target Company for an aggregate consideration of RMB 21.2 million (payable in instalments through 2028), subject to the terms and conditions set forth in the SPA ("Sale"). The Company's board of directors ("Board") reviewed the terms of the SPA, including the consideration, conditions and payment arrangements. The Board affirmed the Seller's entry into the SPA and affirmed that the SPA and the transaction thereunder are fair to, and in the best interests of, the Company and its shareholders as a whole. Due to the prolonged suspension of operations at the Yuxin Chemical facility, which has adversely affected the Company's performance, the Board believes that, following the Sale, it will no longer retain any burdens associated with such facility and will be able to focus resources on its other more profitable business segments. The foregoing description of the SPA does not purport to be complete and is qualified in its entirety by reference to the full text of the SPA, a form of which is filed herein as Exhibit 10.1 to this Current Report on Form 8-K and incorporated herein by reference. to the Company or its management's intentions, hopes, beliefs, expectations or predictions of the future, constitute forward looking in the Company's Annual Report on Fo

01 Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits. Exhibits The following exhibit are filed herewith: Exhibit No. Exhibit Description 10.1 English translation of the form of equity transfer agreement by and between Shouguang City Haoyuan Chemical Company Limited, Shandong Rongyuan Pharmaceutical Co., Ltd. and Shouguang Yuxin Chemical Industry Co., Limited dated December 10, 2025 104 Cover Page Interactive Data File (embedded within the XBRL document)

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. GULF RESOURCES, INC. By: /s/ Min Li Name: Min Li Title: Chief Financial Officer December 15, 2025

View Full Filing

View this 8-K filing on SEC EDGAR